Allied is committed to bringing to market a catalogue of cannabinoid products so patients and customers can enjoy the therapeutic benefits without needing to smoke any plant material.
Additionally, we plan to offer balms, edibles, tinctures and other products intended to help veterans and first responders.
Vertically Integrated Global Sales & Distribution
USA – Tactical ReliefTM
TACTICAL RELIEF™ is manufactured and sold by Savage Consulting, under sub-license from Tactical Relief LLC, an affiliate of Allied. As a test market, the first 500 product units have landed on shelves in the United States. Allied is also actively pursuing product distribution internationally to increase revenue potential.
The TACTICAL RELIEF™ products are intended to be used by veterans suffering from symptoms related to post traumatic stress disorder (PTSD), one of Allied’s top market segment priorities. Allied is dedicated to promoting a holistic approach for healing that reinforces a specialized model of care. The model’s main goal is to assist in preventing suicides among veterans and first responders who are suffering from PTSD or other disorders related to mental health. The flagship product “Liberty” is a hemp derived CBD tincture for sale in the US. Additional products include Tactical Hydration, a CBD infused electrolyte replacement drink and many other products currently in development.
“I’ve been dealing with heavy anxiety and stress which has been affecting my mood and sleep. Since trying Tactical Relief a week ago I am already sleeping better, the anxiety is much more manageable and my mood has increased as a result. I highly recommend Tactical Relief”
Asia – MaXXa Brand
Allied is pleased to announce that it will be expanding its natural health products into the cannabidiol (“CBD”) cosmetic market in Asia, under the brand known as MaXXa. Allied plans to distribute CBD-based cosmetics and natural health products in China, Hong Kong and throughout Asia.
The first products will be under the product name that is the Mandarin symbol for “living life alive.”
By 2024, the CBD market in China alone is forecasted to be worth USD $15 billion, according to Hong Kong-based investment company Regent Pacific Group, citing the beauty and wellness sector as the main driver.